N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation
作者:Junfang Li、Xiaoling Hu、Tian Luo、Yingmei Lu、Yiyue Feng、Honghua Zhang、Dan Liu、Xiaohong Fan、Yuqing Wang、Liming Jiang、Yuying Wang、Xiangyong Hao、Tao Shi、Zhen Wang
DOI:10.1016/j.ejmech.2021.113817
日期:2021.12
we designed a series of N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents based on structure modification on 1,5-naphthyridine derivatives (Topo I inhibitors). Notably, the target compounds I-1 (33.61 ± 1.15 μM) and I-8 (45.01 ± 2.37 μM) were confirmed to inhibit COX-2, while a previous reported compound (1,5-naphthyridine derivative) resulted nearly inactive towards COX-2 (IC50 > 150 μM)
胶质母细胞瘤是最致命的脑肿瘤之一。关键的化学疗法主要是具有适度临床成功的烷化剂。鉴于这种迫切的需求,并受到通过同时使用 Topo I 抑制剂和 COX-2 抑制剂的 II 期试验令人鼓舞的结果的启发,我们设计了一系列N- 2-(苯氨基)苯甲酰胺衍生物作为基于结构修饰的新型抗胶质母细胞瘤药物1,5-萘啶衍生物(Topo I 抑制剂)。值得注意的是,目标化合物I-1 (33.61 ± 1.15 μM) 和I-8 (45.01 ± 2.37 μM) 被证实可抑制 COX-2,而先前报道的化合物 (1,5-萘啶衍生物) 对 COX 几乎无活性-2 (IC 50 > 150 μM)。此外,I-1和与母体化合物1,5-萘啶衍生物相比, I-8具有更高的抗增殖、抗迁移、抗侵袭作用,表明基于母体的修饰成功。此外,I-1在 C6 胶质瘤原位模型 (TGI = 66.7%) 和 U87MG 异种移植模型 (TGI